Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
William Cance
University of Arizona, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
FAKnostics, LLC
Other : The Investigator's spouse is the sole owner and Chief Executive Officer of the Entity. In addition, although not compelled by the PHS regulations, the Investigator's uncompensated role as Chief Scientific Officer of the Entity requires management under the University of Arizona's conflict of interest policies.
The Investigator invented, and the Financial Entity licenses, the intellectual property being studied in the funded research. The funded research is designed to support new indications for the intellectual property invented by the Investigator. The activities of the Financial Entity are related to the subject of the funded research, and the funded research could affect the value of the Financial Entity.
Focal Adhesion Kinase - Tumor Biology and Therapeutics
This research will target FAK scaffolding function and validate it as a therapeutic target using our FAK scaffold inhibitors. It will define molecular mechanisms of sensitivity to FAK scaffold inhibitors compared to FAK-kinase inhibitors. It will define mechanisms of resistance to Y397 FAK scaffold inhibitors and develop ways to overcome this resistance in cancer stem cells and patient-derived xenograft models. In addition, this translational application will develop FAK-related biomarkers in human samples to define subsets of patients/tumors that will respond to FAK-targeted therapeutics and be relevant to clinical trials.
Filed on May 04, 2017.
Tell us what you know about William Cance's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “William Cance”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| William Cance | University of Arizona | Conflict of Interest | FAKnostics, LLC | Value cannot be readily determined |
| William Cance | University of Arizona | Conflict of Interest | FAKnostics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.